The Eye Hospital of Wenzhou Medical University is the lead sponsor of 10 current clinical trials in our China register. 10 are recruiting patients now. The most common phase is Observational. The most-studied condition is Ocular Diseases.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
AI-Driven Prediction of Hospital-Acquired Infections With EHR
NCT06791382 · ClinicalTrials.gov ↗ · Hospital-acquired Infections
|
Observational | Recruiting | 2023-02 | China |
|
Early Diagnosis and Prediction of Maternal and Neonatal Diseases:
NCT06791343 · ClinicalTrials.gov ↗ · Pregnancy-Related and Neonatal Disorders
|
Observational | Recruiting | 2023-08 | China |
|
AI-Driven Cancer Diagnosis and Prediction With EHR
NCT06791473 · ClinicalTrials.gov ↗ · Tumor
|
Observational | Recruiting | 2025-01 | China |
|
AI-Driven Prediction of Biological Age With EHR
NCT06791486 · ClinicalTrials.gov ↗ · Biological Age
|
Observational | Recruiting | 2023-03 | China |
|
AI-Agent for Automated Diagnosis and Predicting Using EHR and Multimodal Data
NCT06791499 · ClinicalTrials.gov ↗ · AI Agent
|
Observational | Recruiting | 2023-07 | China |
|
AI-Assisted Medical Decision-Making
NCT06846229 · ClinicalTrials.gov ↗ · Real-world Study
|
Observational | Recruiting | 2025-02 | China |
|
Ophthalmic AI-Assisted Medical Decision-Making
NCT06755060 · ClinicalTrials.gov ↗ · Ocular Diseases
|
Not applicable | Recruiting | 2024-12 | China |
|
Ophthalmic Multimodal AI-Assisted Medical Decision-Making
NCT06755190 · ClinicalTrials.gov ↗ · Ocular Diseases
|
Observational | Recruiting | 2024-12 | China |
|
AI-Driven Genotype Prediction Using EHR and Multimodal Data
NCT06791421 · ClinicalTrials.gov ↗ · Genotype
|
Observational | Recruiting | 2023-07 | China |
|
AI-Driven Prediction of Dialysis Outcome With EHR
NCT06791447 · ClinicalTrials.gov ↗ · Dialysis Patients
|
Observational | Recruiting | 2023-01 | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 10 | 10 |
A trial with sites in more than one country appears in each of those registers.
The Eye Hospital of Wenzhou Medical University is the lead sponsor of 10 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 10 of its 10 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.